MedTrace Logo

Maternal and Fetal Outcome of CKD Mother Patient in Sohag Governorate

NCT05867459 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2023-05-22

No results posted yet for this study

Summary

Aim of the work:

In this study, we aimed:

Is to investigate the following issues: (1) the pregnancy outcomes of patients with CKD (2) additional risk factors for adverse pregnancy outcomes in patients with CKD in the area of sohag governorate.

Conditions

  • CKD PREGNANT WOMEN

Interventions

DIAGNOSTIC_TEST

Serum creatinine

The test wil be measured for all pt in study to detect of their grade of CKD

DIAGNOSTIC_TEST

Alb /creat ratio or 24h urine protein

Test will be measured to detect type and sevirity of proteinuria

DIAGNOSTIC_TEST

Serum electrolyte

The test will be measured in all pt to detect renal tubular state

DIAGNOSTIC_TEST

Urine analysis

It is mirror of kidney

DIAGNOSTIC_TEST

Abdominal ultrasound

To detect the anatomy and any structural abnormality in kidneys

DIAGNOSTIC_TEST

Renal biobsy

Is done but not for all pt but for pt that can do it and agree for it .the test is used for detection of type of CKD or type of glomerionephritis

OTHER

Clinical assesment

Clinical assessment: age, kidney disease history, history of DM or HTN ,history of pregnancy during study, therapy in early pregnancy , body weight, body height, and . Mean arterial pressure (MAP) . Body mass index (BMI). According to age and Scr level, the estimated glomerular filtration rate (eGFR) was calculated by CKD-EPI Creatinine Equation (2021) Evaluation of pregnancy outcomes :Adverse pregnancy outcomes included maternal death, severe preeclampsia ,eclampsia ,duration of hospital stay and type of care need, mode of delivery ,need of blood transfusion , gestational age during delivary for detet preterm birth early preterm or late preterm from or extremely preterm \> 28W, birth weigh for low birthweight ,very low birth weight , extremely low birth weight,NICU admission,IUGR, still birth ,abortion, and neonatal death.

Sponsors & Collaborators

  • Sohag University

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
52 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-04-01
Primary Completion
2023-12-31
Completion
2023-12-31

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05867459 on ClinicalTrials.gov